Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Vaccines, Synthetic
×
1 year
×
Clear all
Filters
3
NCT00092534
2025-08-01
FUTURE II
Merck Sharp & Dohme LLC
Phase 3
Completed
12,167 enrolled
23 charts